Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Deigma is a French healthtech company developing digital pre-analytical workflow solutions for medical biology laboratories. Its core offering is a connected prescription and home-sample traceability platform that helps laboratories and nurses manage external blood sample collection, improve data quality, reduce administrative burden, and lower pre-analytical errors. The company operates in the diagnostics and laboratory operations segment rather than drug development, and its products appear to be commercially deployed with laboratory customers. Deigma has highlighted interoperability with Roche Diagnostics France systems and has also partnered with LESS France on SmartBag, a connected transport/traceability solution for biological samples. Overall, Deigma is best understood as a private healthcare software and workflow company serving diagnostic laboratories in France.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Deigma.